Position in STOK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,827,759
-$1,009,841 QoQ
Shares Held
178,110
-15.2% QoQ
Ownership
0.276%
of shares outstanding
% of Portfolio
2.75%
of 13F equity value
Holder Rank
#45
of 194 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in STOK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Birchview Capital, LP holds $91,246,272 across 49 Biotechnology names. STOK ranks #3 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SLDB |
Solid Biosciences Inc.
|
666,196 | $6,655,298 | |
| 2 | NTLA |
Intellia Therapeutics, Inc.
|
385,900 | $6,529,428 | |
| 3 | STOK |
Stoke Therapeutics, Inc.
This page
|
178,110 | $5,827,759 | |
| 4 | NKTR |
Nektar Therapeutics
|
81,000 | $5,654,610 | |
| 5 | CORT |
Corcept Therapeutics Inc
|
57,200 | $4,973,540 | |
| 6 | PRTA |
Prothena Corp Public Ltd Co
|
449,019 | $4,395,896 | |
| 7 | ACAD |
Acadia Pharmaceuticals Inc
|
171,000 | $4,326,300 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
35,018 | $4,292,506 |
All Filings in STOK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,827,759 | 178,110 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,837,600 | 210,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,252,400 | 260,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,935,000 | 210,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,383,500 | 210,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,396,533 | 210,005 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,316,300 | 210,000 | Shares | Sole | 2025-06-30 | |
| 2024-09-30 | $2,580,900 | 210,000 | Shares | Sole | 2025-06-30 | |
| 2024-06-30 | $2,837,100 | 210,000 | Shares | Sole | 2025-06-30 | |
| 2024-03-31 | $2,835,000 | 210,000 | Shares | Sole | 2025-06-30 | |
| 2023-12-31 | $1,104,600 | 210,000 | Shares | Sole | 2025-06-30 | |
| 2023-09-30 | $334,900 | 85,000 | Shares | Sole | 2025-06-30 | |
| 2023-06-30 | $903,550 | 85,000 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $124,950 | 15,000 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $138,450 | 15,000 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $192,600 | 15,000 | Shares | Sole | 2022-11-28 | |
| 2022-06-30 | $198,150 | 15,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $315,750 | 15,000 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $359,850 | 15,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $381,600 | 15,000 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $504,900 | 15,000 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $582,600 | 15,000 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,238,600 | 20,000 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $669,800 | 20,000 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $476,600 | 20,000 | Shares | Sole | 2020-09-25 | |
| 2020-03-31 | $458,000 | 20,000 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||